Abstract/References

Acute pancreatitis in children in Japan is often caused by an anatomical abnormality of the pancreatic and bile duct, resulting in fever, abdominal pain, vomiting, diarrhea, and other symptoms.　Crohn’s disease, however, is a chronic granulomatous inflammatory bowel disease with ulcerative lesions of the intestinal tract of unknown cause that occurs mainly in young people, with symptoms similar to those of acute pancreatitis.　We report a case of acute pancreatitis diagnosed in a patient not only with incomplete fusion of the pancreatic duct but also with Crohn’s disease.　A 14-year-old girl, healthy by nature, presented to our hospital with complaints of abdominal pain and diarrhea.　She was initially diagnosed as having acute pancreatitis due to incomplete pancreas divisum.　However, a high level of fecal calprotectin led to endoscopic examination, which resulted in the diagnosis of Crohn’s disease.　Fecal calprotectin can be useful in the diagnosis of inflammatory bowel disease associated with acute pancreatitis in children.　Although the relationship between inflammatory bowel disease and acute pancreatitis has not yet been clarified, we suggest that in the present case, acute pancreatitis may have manifested as a complication of Crohn’s disease and an underlying case of incomplete pancreas divisum.

1. Suzuki M, Fujii T, Takahiro K, Ohtsuka Y, Nagata S, Shimizu T.　Scoring system for the severity of acute pancreatitis in children.　Pancreas, 37(2):222-223, 2008.

2. Kaser A, Zeissig S, Blumberg RS.　Inflammatory bowel disease.　Annu Rev Immunol, 28:573-621, 2010.

3. Fagerberg UL, Lööf L, Lindholm J, Hansson LO, Finkel Y.　Fecal calprotectin:a quantitative marker of colonic inflammation in children with inflammatory bowel disease.　J Pediatr Gastroenterol Nutr, 45(4):414-420, 2007.

4. Uc A, Husain SZ.　Pancreatitis in Children.　Gastroenterology, 156(7):1969-1978, 2019.

5. Harbord M, Annese V, Vavricka SR, et al.　The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease.　J Crohns Colitis, 10(3):239-254, 2016.

6. Rasmussen HH, Fonager K, Sørensen HT, Pedersen L, Dahlerup JF, Steffensen FH.　Risk of acute pancreatitis in patients with chronic inflammatory bowel disease.　A Danish 16-year nationwide follow-up study.　Scand J Gastroenterol, 34:199-201, 1999.

7. Munk EM, Pedersen L, Floyd A, Nørgård B, Rasmussen HH, Sørensen HT.　Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis:a population-based case-control study.　Am J Gastroenterol, 99(5):884-888, 2004.

8. Morinville VD, Husain SZ, Bai H, et al.　Definitions of pediatric pancreatitis and survey of present clinical practices.　Published correction appears in J Pediatr Gastroenterol Nutr, 56(4):459, 2013.

9. Røseth AG, Schmidt PN, Fagerhol MK.　Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease.　Scand J Gastroenterol, 34(1):50-54, 1999.

10. Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB.　Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology.　Aliment Pharmacol Ther, 20(6):615-621, 2004.

11. Konikoff MR, Denson LA.　Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.　Inflamm Bowel Dis, 12(6):524-534, 2006.

12. Turner D, Levine A, Escher JC, et al.　Management of pediatric ulcerative colitis:joint ECCO and ESPGHAN evidence-based consensus guidelines.　J Pediatr Gastroenterol Nutr, 55(3):340-361, 2012.